Compare Ganges Securitie with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.01%
- Poor long term growth as Net Sales has grown by an annual rate of -0.33% and Operating profit at -25.70%
Negative results in Dec 25
With ROE of 0.2, it has a Very Expensive valuation with a 0.2 Price to Book Value
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Ganges Securitie for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAre Ganges Securities Ltd latest results good or bad?
Ganges Securities Ltd's latest financial results present a mixed picture. In Q2 FY26, the company reported net sales of ₹15.51 crores, reflecting a substantial sequential growth of 143.87% from ₹6.36 crores in Q1 FY26, although year-on-year growth was modest at 2.31% compared to ₹15.16 crores in Q2 FY25. The net profit for the same quarter was ₹2.91 crores, which shows a significant sequential improvement of 182.52% from ₹1.03 crores in Q1 FY26, yet it marks a notable decline of 59.70% from ₹7.22 crores in Q2 FY25. The company's operating profit margin (excluding other income) improved to 31.91% in Q2 FY26 from 13.99% in the previous quarter, but it remains below the 58.97% margin achieved in the same quarter last year. The PAT margin also increased to 18.76% from 16.19% in Q1 FY26, but it is substantially lower than the 47.63% recorded in Q2 FY25. A critical concern is the return on equity (ROE), which s...
Read full news article Announcements 
Ganges Securities Limited - Other General Purpose
05-Dec-2019 | Source : NSEGanges Securities Limited has informed the Exchange regarding Disclosure of Related Party Transactions under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019.
Ganges Securities Limited - Clarification - Financial Results
26-Nov-2019 | Source : NSEGanges Securities Limitedurities Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Ganges Securities Limited - Clarification
18-Nov-2019 | Source : NSEGanges Securities Limited with respect to announcement dated 06-Nov-2019, regarding Board meeting held on November 06, 2019. On basis of above the Company is required to clarify following: 1. Name of the entity (ies) forming part of the amalgamation/merger, details in brief such as, size, turnover etc.; 2. Whether the transaction would fall within related party transactions? If yes, whether the same is done at "arm's length"; 3. Area of business of the entity (ies); 4. Rationale for amalgamation/ merger; 5. In case of cash consideration amount or otherwise share entitlement/exchange ratio; 6. Brief details of change in shareholding pattern (if any) of listed entity. The response of the Company is awaited.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 1 FIIs (0.03%)
Sil Investments Limited (13.38%)
Navjeewan Medical Institute (6.21%)
21.88%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -14.20% vs 1.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 82.50% vs -40.30% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -4.41% vs 19.10% in Sep 2024
Growth in half year ended Sep 2025 is -52.87% vs 35.93% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.98% vs 11.81% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -41.05% vs 22.30% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 9.08% vs -15.57% in Mar 2024
YoY Growth in year ended Mar 2025 is 45.40% vs -64.31% in Mar 2024






